Inactive Instrument

Meda AB Stock

Stocks

End-of-day quote Nasdaq Stockholm Other stock markets
- ^SEK	-

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE

20/07/16	Meda : Mylan gets EU approval for Meda purchase, subject to conditions	RE
15/07/16	Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources	RE
02/06/16	Meda : EU regulators to rule on Mylan's $7.2 billion Meda bid by July 6	RE
09/03/16	Valeant Pharmaceuticals Intl : gives Pershing Square one board seat, adds two other directors	RE
11/02/16	Abbott Laboratories : Mylan to buy Swedish drugmaker Meda in $7.2 billion deal	RE
15/01/16	Meda : Swedish drug firm Meda nears deal to sell U.S. business - sources	RE
14/07/14	AbbVie : Shire ready to bow to AbbVie's increased $53 billion offer	RE
12/07/14	Abbott Laboratories : Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
12/07/14	Abbott Laboratories : Exclusive: Mylan near multibillion-dollar deal for Abbott drug assets - sources	RE
15/05/14	Banks vie for fees as Nordic deal scene ignites	RE
06/05/14	Actavis : Factbox - M&A frenzy transforming global pharma	RE
06/05/14	Actavis : M&A frenzy in healthcare sector	RE
01/05/14	Actavis : Pfizer's designs on AstraZeneca stir tax envy among rivals	RE

25/08/16	Meda : Bulletin from the Extraordinary General Meeting in Meda AB (publ)	BU
08/08/16	Meda : Delisting of Meda Aktiebolag (publ)	BU
05/08/16	MEDA: Notice to noteholders regarding change of control	BU
02/08/16	Meda : Aktiebolag (publ) applies for delisting and convenes an extraordinary general meeting	BU
02/08/16	Meda : Extraordinary General Meeting of Meda Aktiebolag (publ)	BU

20/07/16	Mylan NV : La CE autorise Mylan à racheter Meda sous conditions
15/07/16	Meda : L'UE devrait accepter le rachat de Meda par Mylan-sources
11/02/16	Cisco Systems : Wall Street ouvre en net recul
11/02/16	Wall Street ouvre en baisse, craintes sur la croissance mondiale
11/02/16	Meda : BOURSE-Meda s'envole de plus de 70% après son rachat par Mylan

Manager	Title	Age	Since
Lars Henrik Andreas Rejnus CEO	Chief Executive Officer	52	-
Mårten Österlund LAW	General Counsel	69	09/12/2014
Rainer Weiss CTO	Chief Tech/Sci/R&D Officer	64	01/01/2005

Director	Title	Age	Since
Colleen Ostrowski BRD	Director/Board Member	53	25/08/2016
Caroline Rebecca Louise Dixon BRD	Director/Board Member	58	25/08/2016
Lars Henrik Andreas Rejnus CHM	Chairman	52	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	+2.61%	+2.63%	+59.27%	+172.29%	1,070B
JOHNSON & JOHNSON	+2.65%	+4.61%	+71.11%	+66.83%	624B
ABBVIE INC.	-0.06%	+1.29%	+35.84%	+88.10%	450B
ROCHE HOLDING AG	+2.14%	-2.07%	+27.62%	+22.57%	328B
ASTRAZENECA PLC	+1.87%	+1.87%	+40.58%	+42.08%	292B
NOVARTIS AG	+1.36%	+0.17%	+29.90%	+49.33%	284B
NOVO NORDISK A/S	+1.98%	+4.08%	-25.78%	-39.02%	217B
AMGEN INC.	+0.11%	+1.29%	+25.21%	+67.75%	198B
GILEAD SCIENCES, INC.	+3.91%	+6.48%	+20.35%	+80.77%	161B
Average	+1.87%	+0.98%	+31.57%	+61.19%	402.71B
Weighted average by Cap.	+1.99%	+0.70%	+43.05%	+87.57%